NasdaqCM - Nasdaq Real Time Price USD

Profound Medical Corp. (PROF)

6.92
+0.38
+(5.81%)
As of 12:01:19 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,862
10,680
7,199
6,681
6,873
Cost of Revenue
3,838
3,643
2,887
3,660
3,921
Gross Profit
8,024
7,037
4,312
3,021
2,952
Operating Expense
44,375
40,099
32,963
32,623
33,243
Operating Income
-36,351
-33,062
-28,651
-29,602
-30,291
Net Non Operating Interest Income Expense
1,419
1,436
775
919
-310
Other Income Expense
2,976
3,808
-575
301
7
Pretax Income
-31,956
-27,818
-28,451
-28,382
-30,594
Tax Provision
-1
-2
-128
287
105
Net Income Common Stockholders
-31,955
-27,816
-28,323
-28,669
-30,699
Diluted NI Available to Com Stockholders
-31,955
-27,816
-28,323
-28,669
-30,699
Basic EPS
-1.21
-1.12
-1.34
-1.38
-1.50
Diluted EPS
-1.21
-1.12
-1.34
-1.38
-1.50
Basic Average Shares
26,202
24,765.50
21,182.56
20,774.64
20,466
Diluted Average Shares
26,202
24,765.50
21,182.56
20,774.64
20,466
Total Operating Income as Reported
-36,351
-33,062
-28,651
-32,126
-30,291
Rent Expense Supplemental
--
--
715
496
--
Total Expenses
48,213
43,742
35,850
36,283
37,164
Net Income from Continuing & Discontinued Operation
-31,955
-27,816
-28,323
-28,669
-30,699
Normalized Income
-34,930.91
-31,623.73
-27,750.59
-28,891.11
-30,704.15
Interest Income
--
--
1,642
803
205
Interest Expense
--
--
770
174
67
Net Interest Income
1,419
1,436
775
919
-310
EBIT
-36,351
-33,062
-28,651
-28,208
-30,527
EBITDA
-35,502
-32,126
-27,722
-26,604
-28,648
Reconciled Cost of Revenue
3,838
3,643
2,887
3,660
3,921
Reconciled Depreciation
849
936
929
1,604
1,879
Net Income from Continuing Operation Net Minority Interest
-31,955
-27,816
-28,323
-28,669
-30,699
Total Unusual Items Excluding Goodwill
2,976
3,808
-575
301
7
Total Unusual Items
2,976
3,808
-575
301
7
Normalized EBITDA
-38,478
-35,934
-27,147
-26,905
-28,655
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0.09
0.27
-2.59
78.89
1.86
12/31/2021 - 10/29/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRCT PROCEPT BioRobotics Corporation
60.83
+0.33%
 
PAVM PAVmed Inc.
0.6480
+1.49%
 
QTRX Quanterix Corporation
6.33
+4.46%
 
BBLG Bone Biologics Corporation
4.8800
+2.32%
 
PINK.V Perimeter Medical Imaging AI, Inc.
0.2300
-2.13%
 
OWLT Owlet, Inc.
7.04
-0.56%
 
NSPR InspireMD, Inc.
2.4400
+5.19%
 
NPCE NeuroPace, Inc.
11.22
+1.36%
 
TELA TELA Bio, Inc.
1.7350
+2.06%
 
AIMD Ainos, Inc.
0.5229
+3.75%